Read Research Alzheimer's More' title='Share this by email.' class='social email'>           

Analysis of tauopathy research funding between 2006 and 2016 reveals critical gaps in research priorities

Neurodegenerative diseases encompass a range of diagnoses, such as Alzheimer’s disease and Parkinson’s disease. Despite decades of advancements in understanding the neurobiology of individual diseases, this class has few disease-modifying therapeutics and a paucity of biomarkers for diagnosis or progression. However, tau protein aggregation has emerged as a potential unifying Read & Research Alzheimer’s More

Leave a Reply